发明申请
US20130267884A1 Systems and Methods for Achieving Target Post-Procedure Fraction of Cells Remaining, Hematocrit, and Blood Volume During a Therapeutic Red Blood Cell Exchange Procedure With Optional Isovolemic Hemodilution 有权
在治疗性红细胞交换程序中使用任选的异戊二烯血液稀释法实现靶细胞剩余,血细胞比容和血液体积分数的系统和方法

  • 专利标题: Systems and Methods for Achieving Target Post-Procedure Fraction of Cells Remaining, Hematocrit, and Blood Volume During a Therapeutic Red Blood Cell Exchange Procedure With Optional Isovolemic Hemodilution
  • 专利标题(中): 在治疗性红细胞交换程序中使用任选的异戊二烯血液稀释法实现靶细胞剩余,血细胞比容和血液体积分数的系统和方法
  • 申请号: US13840113
    申请日: 2013-03-15
  • 公开(公告)号: US20130267884A1
    公开(公告)日: 2013-10-10
  • 发明人: Daniel R. BoggsKyungyoon MinLan T. NguyenJohn T. FoleyBrian Case
  • 申请人: FENWAL, INC.
  • 申请人地址: US IL Lake Zurich
  • 专利权人: FENWAL, INC.
  • 当前专利权人: FENWAL, INC.
  • 当前专利权人地址: US IL Lake Zurich
  • 主分类号: A61M1/38
  • IPC分类号: A61M1/38
Systems and Methods for Achieving Target Post-Procedure Fraction of Cells Remaining, Hematocrit, and Blood Volume During a Therapeutic Red Blood Cell Exchange Procedure With Optional Isovolemic Hemodilution
摘要:
Systems and methods for performing a therapeutic red blood cell exchange procedure are disclosed. In one aspect, a system includes a first flow path for flowing whole blood from a patient. A separator communicates with the first flow path for separating at least red blood cells from plasma. Second and third flow paths communicate with the separator for respectively flowing the separated plasma and red blood cells from the separator. A flow controller is associated with the flow paths to control fluid communication between the flow paths. The controller is configured to perform the procedure to achieve a target fraction of patient cells remaining, target hematocrit, and a target patient fluid volume change at the completion of the procedure based on data input by the operator.
信息查询
0/0